PT - JOURNAL ARTICLE AU - Juyal, Garima AU - Sood, Ajit AU - Midha, Vandana AU - Singh, Arshdeep AU - Singh, Dharmatma AU - Mahajan, Ramit AU - Verma, Vijay AU - Bhatnagar, Rakesh AU - Joshi, Mohan C TI - Correlation between faecal microbial taxa and ulcerative colitis in different phases of disease activity in a north Indian cohort AID - 10.1101/2021.12.12.21267614 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.12.21267614 4099 - http://medrxiv.org/content/early/2022/01/07/2021.12.12.21267614.short 4100 - http://medrxiv.org/content/early/2022/01/07/2021.12.12.21267614.full AB - Background and Aims A link between gut microbiota and Ulcerative colitis (UC) has been established in several studies. However, only a few studies have examined specific changes in microbiota associated with different phases of disease activity in UC. In this study, we attempted to identify differentially abundant taxa between (i) UC patients and healthy controls and (ii) different phases of disease activity, in a genetically distinct north Indian (NI) population.Methods 16S rRNA (V3–V4) sequencing of 105 patients with UC [newly diagnosed (n=14); patients in remission (n=36) and active disease (relapse, n=55)]; and 36 healthy controls was performed and analysed.Results Lower gut microbial diversity; enrichment of lactate-producing bacteria namely Streptococcus, Bifidobacterium and Lactobacillus; and depletion of butyrate-producing bacteria (e.g., Lachnospiraceae and Ruminococcaceae), were observed among UC patients. Subgroup analysis revealed differential abundance of Escherichia-Shigella, Streptococcus, Enterococcus and Faecalibacterium in newly diagnosed UC patients. No discrete microbial features were observed between patients in remission and those with active disease. Co-occurrence network analysis revealed a mutualistic association between opportunistic pathogens and Bifidobacterium and Lactobacillus and antagonistic relationship with butyrate-producers.Conclusion This first faecal microbiome study among NI UC cohort elucidated dysanaerobiosis; loss of short chain fatty acid producers and enrichment of inflammation associated microbes; population specific differential microbial genera; and a potential microbial signature for early dysbiosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Science and Engineering Research Board, New Delhi, vide F. NO. SB/YS/LS-191/2014Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional ethics review board of Jawaharlal Nehru University, New Delhi and Dayanand Medical College and Hospital, Ludhiana approved the study (IEC numbers 2017/SERB Young Scientist/125 and DMCH/R&D/2015/238 respectively) approved the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors